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H.  MEADOR- 
ABSTRACT  Cultured  rat Schwann ceils were treated  for  72  h with axolemma-  and  myelin- 
enriched  fractions prepared from rat brainstem. [3H]Thymidine  was added to the cultures 48 
h  before  the  termination  of  the  experiment.  Although,  both  fractions  produced  a  dose- 
dependent uptake  of label into Schwann cells, the shape of the dose response curves and 
rates  at  which  [3H]thymidine  was  incorporated  were  different.  The  axolemma-enriched 
fraction  produced  a sigmoid  dose response curve  with a Hill  coefficient  of 2.05. The dose 
response curve for myelin rose sharply and saturated at a level that was ~50% of the maximal 
response observed  with  axolemma.  Schwann cells that  had  been  treated  with  axolemma 
exhibited  little  change in  the  rate of  [3H]thymidine  incorporation  from  36-72  h  after  the 
addition of the membranes.  In contrast, Schwann cells accumulated  label three  times faster 
during the 48-72-h period  following the addition of myelin  to the cultures when compared 
with the rate during the preceding  12-h interval.  Furthermore,  the mitogenic  activity  of the 
myelin-enriched  fraction  was decreased by the addition of ammonium chloride,  a lysosomal 
inhibitor, whereas the activity  of the axolemmal fraction was not impaired. 
Schwann  cells  proliferate during development (2,  20)  and 
Wallerian degeneration (4,  10). Using cultured neurites and 
Schwann cells from rat dorsal root ganglia, Salzer and Bunge 
(15) demonstrated that the developmental signal was provided 
by the growing axon. Morphological studies (1,  12, 21) sug- 
gested that the increase in the number of cells during Waller- 
Jan degeneration was proportional to the size  of the myeli- 
nated fiber. Indirect evidence for myelin as a mitogenic signal 
was provided by Salzer and Bunge (15) who found that only 
Schwann cells that had produced myelin proliferated during 
Wallerian degeneration. 
The nature of the axonal signal has been investigated using 
membrane fractions derived from cultured neurites (6,  16, 
17)  or  PC  12  cells  (14)  and  axolemma-enriched fractions 
prepared from central and peripheral nervous tissue (6, 8, 9, 
19). Two studies (6, 9) have reported that myelin-enriched 
fractions were slightly mitogenic for cultured Schwann cells; 
however, the authors were unable to determine whether the 
activity was intrinsic to myelin membranes or due to contam- 
inating axolemmal membranes. 
In the present study, we demonstrate the presence of two 
distinct mitogenic activities in  fractionated nervous tissue. 
Axolemma- and myelin-enriched fractions prepared from rat 
brainstem were found to stimulate the incorporation of [3H]- 
thymidine by cultured  Schwann  cells.  The two  mitogenic 
activities could be differentiated  by their dose response curves, 
the  rate  at  which  they  stimulate  uptake  of label  into  the 
Schwann cells, and their sensitivity to the lysosomal inhibitor, 
ammonium chloride. 
MATERIALS AND  METHODS 
HF media' is Dulbecco's modified Eagle's Medium (Oibco Laboratories, Grand 
Island, NY) with sodium bicarbonate and 10% fetal calf serum (Sterile Systems, 
Logan, UT). Saline I is a balanced salt solution containing  138 mM NaCl, 5.4 
mM KCI, 1.1 mM Na2PO+, 1.1  mM KH2PO4, and 22 mM dextrose, pH 7.0. 
Preparation  of Schwann  Cells:  Schwann cells were prepared  ac- 
cording to the methods of Brockes et al. (5)+ Briefly, sciatic nerves from 2<l- 
old rat pups were excised and treated with trypsin and collagenase. The mixture 
was triturated  with a Pasteur pipette and filtered through 209-zm Nitex (Tetko 
Inc.. Elmsford, NY). Cells were collected by centrifugation  (900 g, 5 rain) and 
suspended in 10 ml of HF and plated at a density of 3-4.5  x  106 cells per 10- 
cm dish. 24 h later the antimitotic  drug, cytosine arabinoside, was added at a 
final concentration  of 10  -5 M. 3 d later the media was removed and replaced 
~  Abbreviations used in this paper:  HF (media), Dulbecco's modified 
Eagle's medium with sodium bicarbonate and  10%  fetal calf serum. 
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FIGURE  1  [3H]Thymidine  incorporation  by  Schwann  cells  stimu- 
lated  with  membrane  fractions.  Values  have  been  corrected  for 
controls (50-100 cpm) and are means __+ SEM for n =  three or four 
determinations. Axolemma- (e) or myelin- (I)  enriched  fractions 
were added to the Linbro well to give a final volume of 100 #1.24 
h  later, 0.3/~Ci  of [3H]thymidine  in 25 ~1 of HF was added.  72  h 
after the  addition  of the  mitogen,  the  cells  were  harvested and 
counted. 
with HF. To eliminate  any fibroblasts that survived the incubation with cytosine 
arabinoside, we treated the cultures with anti-Thy 1.1 (New England Nuclear, 
Boston, MA) and rabbit complement (Cappel Laboratories, Inc., Cochranville, 
PA). This procedure produced cultures that contained 99.5% Schwann cells. 
[3H]Thymidine Incorporation Assay:  After  the  cultures  were 
treated  with  anti-Thy  l.l,  the  cells were  plated  in  96-well dishes  (Linhro 
Chemical Co., Hamden, CT) at a density of 10,000 cells per well. 24 h later the 
mitogen or HF was added to bring the total volume in each well to 100 #1. 1 d 
later 0.3 ~Ci of [aH]thymidine (New England Nuclear,  15 Ci/mmol) in 25 ~1 
of HF was added to each well. 48 h after the addition of the label, the cells were 
treated with 0.005%  trypsin and 0.02%  EDTA  and were collected on  filter 
paper using a  Titertek (Flow Labs,  Inc.,  McLean,  VA)  cell harvester. The 
radioactivity on the filters was determined in an lntertechnique SL 3-scintilla- 
tion counter (in/US Service Corp., Fairfield, N J). 
Autoradiography  of  Mitogen-treated Schwann Cells: 
Schwann cells were plated onto glass coverslips in 24-well plastic culture dishes 
at a  density of 40,000 to 50,000 cells per well after treatment with anti-Thy 
I. 1. Mitogens or HF were added to give a final volume of 500 ul per coverslip. 
24 h  after mitogen addition,  1.5 uCi of [SH]thymidine in  125 #1 of HF was 
added  to  each  eoverslip. 2  d  later the cells were washed and  processed for 
autoradiography as previously described (8).  A  minimum of eight randomly 
selected fields with at least a total of 1,000 cells were counted for each coverslip. 
Preparation  of  Axolemma- and  Myelin-enriched Frac- 
tions:  Axolemma- and myelin-enriched  fractions were prepared from I gram 
of rat brain stem as previously described (7) with minor modifications. The 
shocked myelinated axons were separated on a  34-ml linear sucrose gradient 
(10-40%  sucrose [wt/wt],  in  10  mM  N-tris[hydroxymethyl]methyl-2-amino- 
ethane sulfonic acid with 0.2% sodium azide) by centrifugation at 85,000 g for 
15-18 h.  Those fractions that were between 28 and 32% sucrose (wt/wt) and 
those between 17 and 19% sucrose (wt/wt) were pooled for the axolemma- and 
myelin-enriched fractions, respectively. The samples were collected by centrif- 
ugation and resuspended in sterile Saline 1 to give a concentration of membrane 
protein between 1 and 3 mg/ml. Protein was determined using the microassay 
of Bradford (3) in the presence of 0.1 N NaOH with a gammaglobulin standard. 
RESULTS 
Stimulation of [3H]Thymidine Incorporation by 
Cultured Schwann Cells with Axolemma- and 
Myelin-enriched  Fractions 
Axolemma-enriched fractions stimulated a dose-dependent 
incorporation of [3H]thymidine into Schwann cells (Fig.  l). 
The  myelin-enriched  fraction  also  increased  the  levels  of 
[3H]thymidine uptake into Schwann cells in a dose-dependent 
manner; however, the shape of the curve was different from 
the results obtained when axolemma was used as the mitogen. 
At lower concentrations, myelin stimulated a larger accumu- 
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lation of [3H]thymidine into Schwann cells than the corre- 
sponding dose of axolemma. As the levels of the  mitogens 
were increased, the axolemma-enriched fraction became more 
potent than myelin in promoting the accumulation of label 
within the cells. 
Radioautography of Schwann Cells Stimulated 
with Axolemma- and Myelin-enriched  Fractions 
Schwann cells stimulated with the two mitogens were ex- 
amined by radioautography to confirm the results obtained 
with the cell harvester. The axolemma-enriched fraction stim- 
ulated a  dose-dependent increase in  the number of labeled 
Schwann cells (Fig. 2). The myelin-enriched fraction was more 
mitogenic  for  Schwann  cells  than  the  axolemma  at  lower 
doses,  which agreed with the results observed with the cell 
harvester. Furthermore, higher concentrations of myelin were 
less mitogenic than a comparable level of axolemma. 
Is the Mitogenic Activity of the Myelin Fraction 
Due to Contaminating Axolemmal  Membranes? 
The axolemma- and myelin-enriched fractions appear to 
represent separate mitogenic signals based on their different 
dose response curves.  The dose-dependent incorporation of 
label produced by the myelin, however, may be due to con- 
taminating axolemmal membranes and to an intrinsic inhib- 
itory  factor  in  myelin  that,  at  high  concentrations,  would 
prevent the stimulatory effect of the axolemma. 
Schwann cells were incubated with different concentrations 
of the axolemma-enriched fraction and harvested 12, 24, and 
48 h after the addition of the [3H]thymidine (Fig.  3). Myelin 
was also added  to cultures in  parallel and harvested at the 
same intervals.  12 h after the addition of the label, Schwann 
cells that had been treated with 8 ttg of the myelin-enriched 
fraction (arrowhead, Fig. 3) accumulated the same amount of 
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FIGURE  2  Autoradiography of Schwann cells stimulated with axo- 
lemma- or myelin-enriched fractions. Values are means _+ SD for n 
=  3.  Between 0.2 and 0.4% of the untreated Schwann cell nuclei 
were labeled with [3H]thymidine. To facilitate comparison with Fig. 
1,  the  abscissa  was  chosen  to  express  the  amount  of  mitogen, 
axolemma- (0) or myelin- (I) enriched fractions,  present per  100 
~1 of media. 3 
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hGure  3  Dose-dependent  incorporation  of  [3H]thymidine  by 
Schwann cells stimulated with an axolemma-enriched fraction. Val- 
ues  have been corrected  for  controls  (50-100  cpm)  and  are the 
means +_ SEM for n -  three or four determinations. Schwann cells 
were incubated 24 h with the axolemma-enriched fraction before 
the addition of [3H]thymidine. The cells were harvested 12 h  (il), 
24  h  (II),  and 48  h  NI,) after the addition of the label. 8  ~.g of a 
myelin-enriched fraction (arrowheads) was added to sister cultures 
and harvested at the same intervals. 
[3H]thymidine as Schwann cells that had been incubated with 
1 #g of the axolemma. 24 and 48 h after the addition of  the 
label, the identical concentration of myelin (arrowheads, Fig. 
3) produced mitogenic responses equivalent to ~2 and 3/zg, 
respectively, of the axolemma-enriched fraction. 
The mitogenic activity of the myelin fraction may be due 
to axolemmal contamination and myelin membranes may 
act to delay or inhibit the ability of the axolemma to express 
its stimulatory effect. Schwann  cells  were treated with the 
myelin-enriched fraction to allow the myelin to interact with 
the cells. After 24 h, [3H]thymidine and the axolemmal frac- 
tion were then added to these cultures. The experiment was 
terminated 24 h after the addition of the label, because the 
myelin membranes, if inhibitory, appeared to exert the great- 
est influence up to 24 h after the addition of  the [3H]thymidine 
(Fig.  3).  The  combination  of the  myelin  and  axolemma 
stimulated the incorporation of [3H]thymidine into 10.2% of 
the Schwann cells, whereas myelin alone labeled 6.9% of the 
cells (Fig. 4). The axolemma-enriched fraction, when added 
simultaneously with the label, stimulated the incorporation 
of [3H]thymidine into 4.7% of the Schwann cells. 
Rate of [3H]Yhymidine Incorporation by 
Schwann Cells 
[3H]Thymidine was added to Schwann cells that had been 
treated with either axolemma- or myelin-enriched fractions 
for 24 h. The cells were harvested at 12-, 24-, or 48-h intervals 
following the  addition  of the  label  (Fig.  5).  The  rates  of 
thymidine incorporation appeared linear with time for the 
axolemma-treated Schwann cells. In contrast, the rate of  label 
accumulated by the Schwann cells  stimulated with myelin 
appeared to increase during the last 24 h. The rates of [3H]- 
thymidine incorporation were calculated for four levels  of 
mitogen (Table I). The myelin-treated Schwann cells on the 
average incorporated [3H]thymidine three times faster during 
the final 24-h labeling period when compared with the rate 
during the prior  12-h interval. When a similar comparison 
was made for the axolemma-treated Schwann cells, the aver- 
age rate for the two periods was the same. 
Effect of Ammonium Chloride on the Mitogenic 
Activity of Axolemma- and Myelin- 
enriched Fractions 
During Wallerian degeneration the appearance of myelin 
in lysosomes of Schwann cells (18) and increased lysosomal 
activity (11) accompanied a period of rapid proliferation of 
the Schwann cells.  If the mitogenic activity of the myelin- 
enriched fraction for cultured Schwann cells were dependent 
upon a similar pathway, the addition of the lysosomal inhib- 
itor ammonium chloride (13) should decrease the incorpora- 
tion of [3H]thymidine. To examine this we added axolemma- 
or myelin-enriched fractions to Schwann cells in the presence 
of 6  or 9  mM  ammonium  chloride (Fig.  6).  Whereas the 
mitogenic activity of the  myelin fraction was  significantly 
decreased by the addition of ammonium chloride, the ability 
of  the axolemma-enriched fraction to stimulate incorporation 
of label was not compromised. We also added myelin- and 
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FIGURE  4  Effect of myelin 
membranes  on  the  mito- 
genic activity of axolemma. 
Values are the means +  SD 
for n  =  3. The  myelin-en- 
riched  fraction was added 
to  the  Schwann  cells  to 
achieve a  final  concentra- 
tion  of S  /zgl0.1  ml.  After 
24  h,  [3H]thymidine  and 
the  axolemma-enriched 
fraction  (final  concentra- 
tion  4  #g/0.1  ml)  were 
added to the cultures. The 
cells  were  washed  and 
processed  for  radioautog- 
raphy  24  h  later.  Sister  cultures  were  incubated  with  only  the 
myelin- or the axolemma-enriched fraction at the concentrations 
described above. The axolemmal fraction and the label were added 
to the sister culture simultaneously. 
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FIGURE  5  Rates of [3H]thymidine incorporation by Schwann cells 
stimulated with axolemma- or myelin-enriched fractions. Values are 
the  means  of  three  or  four  determinations.  Axolemma-  (0)  or 
myelin- (II) enriched fractions were added at the level (micrograms) 
indicated on the figure. 24 h later, [3H]thymidine was added to the 
wells as described previously. The cells were harvested and counted 
at the intervals indicated. 
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cells in the presence or absence of 6 mM ammonium chloride. 
In the presence of the inhibitor, the combined fractions pro- 
duced  labeling of the  Schwann  cells equivalent to that ob- 
served with the axolemma-enriched fraction alone. 
Cooperative Nature of [3H]Thymidine 
Incorporation by Cultured Schwann Cells 
Stimulated with the Axolemma-enriched Fraction 
The dose-dependent incorporation of label into Schwann 
cells stimulated with axolemma was examined more carefully 
(Fig.  7) because the data in Fig.  ! did not generate a simple 
TABLE I 
Rates of [31-t]Thymidine  Accumulation by Schwann Cells 
Stimulated with Axolemma- or Myelin-enriched Fractions 
Mitogen  Axolemma  Myelin 
concen- 
tration  Rate I*  Rate I1'  II/I  Rate I*  Rate I1'  II/I 
#g/well  cpm/h  cpm/h 
1.0  4.0  3.1  0.7  5.0  19.2  3.8 
2.0  7.8  15.0  1.9  14.6  28.1  1.9 
4.0  48.0  33.0  0.7  10.5  39.8  3.8 
8.0  48.0  63.0  1.3  15.4  35.5  2.3 
X" =  1.2  --- 0.6  ~  X  =  3.0 +  1.0  tm 
* Rate of [3H]thymidine  incorporation  from  12-24  h following  addition  of 
label (36-48 h after addition of mitogen). 
* Rate of [3H]thymidine  incorporation  from 24-48  h following addition  of 
label (48-72 h after addition of mitogen). 
* These values represent the means ± SD of rate II/rate I. 
I The means  are statistically different by Student's t test (p < 0.01). 
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FIGURE  6  Effect of ammonium chloride on the mitogenic activities 
of the axolemma- or myelin-enriched fractions. The values are the 
means +  SD for n =  3. Schwann cells were treated with axolemma 
(5/zg/0.1  m]) or with myelin (2 pg/0.1 ml) in the presence or absence 
of ammonium chloride. After 24 h [3H]thymidine was added to the 
cultures, and 48 h  later the cells were washed and processed for 
radioautography. The means (asterisk)  are statistically different  by 
Student's t test (P <  0.01) when compared with cells that were not 
treated with ammonium chloride. A set of Schwann cells was treated 
with  both  axolemma and  myelin  (same  doses  as  above)  in  the 
presence or absence of 6 mM ammonium chloride. Control cultures 
typically  had  one  or  two  cells  labeled  per  1,000.  Labeling  of 
Schwann cells that were treated with only ammonium chloride was 
approximately five to seven cells per 1,000. 
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FiGure  7  Dose  response curve  and  Hill  plot  for  Schwann  cells 
stimulated with axolemma-enriched fractions. (A) Values are means 
__+ SEM for n  =  4.  Axolemma was added to give a final volume of 
100 #1 in each Linbro well. (B) Results  from A  were replotted with 
the appropriate Hill coordinates. The slope of the curve was 2.05, 
and 3,500 cpm was chosen as the value for the maximum. 
curve that would pass through the origin. The results from 
Fig.  7A  were  replotted in  the  appropriate Hill  coordinates 
which produced a  straight line with a  slope of 2.05.  Three 
other dose response curves were analyzed in a similar fashion 
and produced slopes of 1.65, 2.1, and 2.4.  A Hill coefficient 
(the value of the slope) greater than unity describes a reaction 
that exhibits positive cooperativity. 
DISCUSSION 
Both  axolemma-  and  myelin-enriched  fractions  prepared 
from rat  brain  stem stimulated  the  incorporation  of [3H]- 
thymidine into cultured Schwann cells. Increasing concentra- 
tions of axolemma produced a sigmoid curve that possessed 
a Hill coefficient of 2 when the results were replotted in the 
appropriate Hill coordinates.  The simplest interpretation of 
this observation is that the binding of two molecules in the 
axolemmal fraction to the Schwann cell is required to stimu- 
late uptake of label into Schwann cells. Other studies (6,  19) 
have described  a  dose-dependent  relationship  between  the 
concentration  of the  axolemma-enriched  fraction  and  the 
incorporation of labeled material into Schwann cells, but too 
few points were examined in the linear region of the curve to 
permit a detailed analysis of  the response. Also, Schwann cells 
in  our  study  were  incubated  24  h  longer  with  both  the 
axolemma-enriched fraction and [aH]thymidine. 
The relationship between increasing concentrations of mye- 
lin and the accumulation of [3H]thymidine within Schwann 
cells  was not identical  to the  response elicited by the  axo- 
lemma-enriched fraction. Although myelin was a more potent 
stimulus  at  lower concentrations  than  the  axolemma,  the 
actual mass added to the cultures may be equivalent because 
of the imbalance in the lipid-to-protein ratios in these frac- 
tions. Nonetheless, the maximum incorporation of label pro- 
duced by the myelin membranes was approximately one half 
that observed with the axolemma. Similar curves were ob- 
tained when Schwann cells stimulated with the mitogens were 
examined by radioautography. 
However, the possibility exists that the stimulatory effect of 
the myelin-enriched fraction may result from contaminating 
axolemmal membranes. The  mitogenic activity of a  fixed 
concentration of the myelin fraction was determined at dif- 
ferent intervals following the addition of the [3H]thymidine 
and compared with  the corresponding dose response curve 
generated by the axolemma-enriched fraction. Prolonged ex- posure of a myelin fraction to cultured Schwann cells cannot 
lead  to  a  threefold  increase  of axolemmal contamination; 
more  likely,  the  observed  mitogenicity  is  intrinsic  to  the 
myelin membranes themselves. 
Alternatively, myelin membranes may be acting to delay 
or inhibit the expression of mitogenic activity of any contam- 
inating axolemmal membranes in the myelin-enriched frac- 
tion. Schwann cells were incubated with the myelin-enriched 
fraction before addition  of the axolemma-enriched fraction 
to allow the myelin membranes to interact first with the cells. 
When these cultures were compared with others treated with 
either myelin or axotemmal fractions alone, the myelin mem- 
branes did not substantially diminish the ability of the axo- 
lemma to stimulate the incorporation of [3H]thymidine. 
The rates of [3H]thymidine incorporation by Schwann cells 
were not equivalent when myelin-treated cells were compared 
with those incubated with axolemma. The rate of [3H]thy- 
midine accumulation by Schwann cells stimulated with axo- 
lemma during the last 24 h (48-72 h after addition of mitogen) 
was essentially unchanged compared with the preceding 12-h 
interval (36-48 h following addition of mitogen). In contrast, 
the  myelin-treated Schwann  cells  incorporated  label  three 
times  faster during  the  final  24-h  period  than  during  the 
preceding  12  h.  This sudden  increase coincides temporally 
with an increase in Schwann cell proliferation during Waller- 
ian degeneration in vitro (4) and in vivo (15). 
The accumulation of myelin debris within  Schwann  cell 
lysosomes (18)  and  an  increase  in  lysosomal activity  (11) 
accompanies the period of intense Schwann cell proliferation 
during Wallerian degeneration. If myelin acts as a mitogenic 
signal for Schwann cells, the membranes may require proc- 
essing through the lysosomal compartment of the cell prior 
to activating ceil division. Cultured Schwann ceils were treated 
with axolemma- or myelin-enriched fractions in the presence 
of the lysosomal inhibitor ammonium chloride.  The mito- 
genie  activity of the  myelin  fraction  was  significantly de- 
creased by the inhibitor, whereas the activity of  the axolemma 
was  not.  When  axolemma- and  myelin-enriched  fractions 
were added to the same cultures with ammonium chloride, 
the  labeling  of the  Schwann  cells  was  equivalent  to  that 
observed when only axolemma was present. The presence of 
endocytosed  myelin  in  Schwann  cells,  which  may  not  be 
degraded as a consequence of impaired lysosomal function, 
does not appear to inhibit the mitogenicity of the axolemma- 
enriched fraction. 
Two distinct mitogenic signals for cultured Schwann cells 
can be distinguished in fractionated nervous tissue. Our results 
provide direct evidence for the participation of myelin mem- 
branes  in  Schwann  cell  proliferation  in  vitro  which  may 
correspond to the mitogenic events occurring during Waller- 
ian degeneration. Whether the mitogenic activity of the axo- 
lemma-enriched fraction is related to the axonal stimulus for 
Schwann cells during development remains to be resolved. 
Purification of the mitogen from both fractions will demon- 
strate whether the differences are due to the molecular struc- 
ture  of the  mitogen  or  to  the  environment  in  which  the 
mitogen resides. Future studies will extend our present obser- 
vations  and  examine  the  mechanisms  by  which  the  two 
membrane fractions exert their  respective mitogenic influ- 
ence. 
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